Angela Talley
Chief Tech/Sci/R&D Officer presso SPERO THERAPEUTICS, INC.
Profilo
Angela Talley is currently working as the Senior Vice President of Clinical Development at Spero Therapeutics, Inc. She previously worked as the Executive Director of Clinical Development at Allergan Ltd.
Dr. Talley holds a doctorate degree from the Icahn School of Medicine at Mount Sinai.
Posizioni attive di Angela Talley
| Società | Posizione | Inizio |
|---|---|---|
| SPERO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Precedenti posizioni note di Angela Talley
| Società | Posizione | Fine |
|---|---|---|
| ALLERGAN PLC | Corporate Officer/Principal | - |
Formazione di Angela Talley
| Icahn School of Medicine at Mount Sinai | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SPERO THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
- Borsa valori
- Insiders
- Angela Talley
